Noteworthy, hypermethylation of the Hpa2 promoter was reported to down-regulate Hpa2 expression, and the resulting low levels of Hpa2 were associated with shorter survival of colorectal cancer patients [43]. This evidence concerns the gene HPSE2 and colorectal cancer.